Skip to content

The Effects of Mannose Supplementation on Glycosylation and Protein Levels in Human Sera

The Effects of Mannose Supplementation on Glycosylation and Protein Levels in Human Sera

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06507735
Enrollment
6
Registered
2024-07-18
Start date
2024-10-29
Completion date
2024-11-06
Last updated
2025-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physiological Stress

Brief summary

The purpose of our study is to investigate the effects of supplemental mannose on sera of humans who are healthy. We will perform proteomics studies to elucidate changes to glycan structure and protein level changes. We hypothesize that we may find that mannose supplies more properly glycosylated protein substrate and helps expedite protein synthesis, that excess mannose leads to alternative glycan structures which confer improved stability, or that there are new sites that become glycosylated after mannose supplementation.

Detailed description

Subjects will be enrolled and a baseline blood sample taken. Subjects will take mannose supplements for 1 week (3-4 packets of a standard dose in water), then a follow up blood sample will be taken. Subject blood will be analyzed by proteomic analysis for 1) change in glycan structure or 2) other protein based approaches to measure changes in levels of proteins.

Interventions

DIETARY_SUPPLEMENTMannose

Mannose is a sugar monomer that is important in the glycosylation of many proteins. The concentration of mannose in mammalian plasma is \ 50-100 μM, which is primarily derived from N-glycan processing. Taking dietary mannose supplements can raise the levels of plasma mannose by 3- to 5-fold. There are currently no known adverse effects of mannose supplementation in humans.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age * No known medical conditions * Taking no medications or nutritional supplements * Agree to the study and provide informed consent

Exclusion criteria

* Less than 18 years of age * Known medical diagnosis, including pregnancy * Presently taking medications and/or nutritional supplements * Do not provide consent

Design outcomes

Primary

MeasureTime frameDescription
Changes to glycan structure~1 monthGlycopeptide mass spectrometry will be applied to the major glycoproteins present in serum.
Change in glycoprotein levels~1 monthStandard laboratory methods such as ELISA in either research or clinical laboratory settings (Roche Cobas or similar platform).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026